Dawell Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 29-10-2024
- Paid Up Capital ₹ 0.10 M
as on 29-10-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.21 M
as on 29-10-2024
- Revenue 4766.58%
(FY 2022)
- Profit 133544.44%
(FY 2022)
- Ebitda 208558.94%
(FY 2022)
- Net Worth 276.79%
(FY 2022)
- Total Assets 4265.23%
(FY 2022)
About Dawell Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.21 M.
Vaibhav Dhasal and Yogesh Katare serve as directors at the Company.
- CIN/LLPIN
U24230PN2020PTC193976
- Company No.
193976
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Sep 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dawell Lifescience?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaibhav Dhasal  | Managing Director | 11-Sep-2020 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Yogesh Katare | Director | 12-Mar-2021 | Current |
Financial Performance of Dawell Lifescience.
Dawell Lifescience Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 4766.58% increase. The company also saw a substantial improvement in profitability, with a 133544.44% increase in profit. The company's net worth Soared by an impressive increase of 276.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dawell Lifescience?
Unlock access to Dawell Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Avf Creative Brand Consultancy Private LimitedActive 6 years 10 monthsVaibhav Dhasal and Yogesh Katare are mutual person
Agrovision Farmers Producer Company LimitedActive 11 years 2 monthsVaibhav Dhasal and Yogesh Katare are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 Nov 2023 | ₹5.00 M | Open |
Hdfc Bank Limited Creation Date: 02 Dec 2021 | ₹1.21 M | Open |
How Many Employees Work at Dawell Lifescience?
Dawell Lifescience has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dawell Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dawell Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
